Want to see SE:CLBIO full AI Analyst Report?
Corline Biomedical AB (CLBIO) Financial Statements
Corline Biomedical AB Financial Overview
Corline Biomedical AB's market cap is currently $371.09M. The company's EPS TTM is $-0.49; its P/E ratio is -28.83; Corline Biomedical AB is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 7.65M | $ 9.78M | $ 25.03M | $ 23.55M | $ 7.06M |
| Gross Profit | $ -14.21M | $ 13.44M | $ 28.38M | $ 22.73M | $ 9.10M |
| Operating Income | $ -14.21M | $ -23.17M | $ -1.79M | $ 2.33M | $ -6.91M |
| EBITDA | $ -14.12M | $ -23.07M | $ -1.69M | $ 2.38M | $ -6.88M |
| Net Income | $ -14.71M | $ -23.19M | $ -1.81M | $ 2.33M | $ -6.92M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 20.56M | $ 17.67M | $ 17.01M | $ 26.21M | $ 41.63M |
| Total Assets | $ 98.58M | $ 94.76M | $ 100.11M | $ 101.78M | $ 101.66M |
| Total Debt | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Net Debt | $ -20.56M | $ -17.67M | $ -17.01M | $ -26.21M | $ -41.63M |
| Total Liabilities | $ 4.82M | $ 7.85M | $ 6.79M | $ 7.19M | $ 9.43M |
| Stockholders' Equity | $ 93.76M | $ 86.91M | $ 93.32M | $ 94.59M | $ 92.23M |
| Cash Flow | |||||
| Free Cash Flow | $ -17.74M | $ -16.14M | $ -9.73M | $ -15.45M | $ -14.45M |
| Operating Cash Flow | $ -17.69M | $ -8.64M | $ 886.00K | $ -6.45M | $ -4.83M |
| Investing Cash Flow | $ -982.00K | $ -7.50M | $ -10.62M | $ -9.00M | $ -9.56M |
| Financing Cash Flow | $ 21.56M | $ 16.79M | $ 537.00K | $ 26.00K | $ 47.13M |
Currency in SEK